Sean Werner's most recent trade in Biolife Solutions Inc was a trade of 1,681 Common Stock done at an average price of $19.1 . Disclosure was reported to the exchange on March 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.12 per share. | 19 Mar 2026 | 1,681 | 48,251 (0%) | 0% | 19.1 | 32,141 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 03 Mar 2026 | 111 | 49,932 (0%) | 0% | 20.7 | 2,302 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 24,116 | 50,043 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.74 per share. | 25 Nov 2025 | 110 | 25,927 (0%) | 0% | 26.7 | 2,941 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 20 Oct 2025 | 275 | 26,037 (0%) | 0% | 27.8 | 7,651 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.83 per share. | 11 Sep 2025 | 72 | 26,312 (0%) | 0% | 26.8 | 1,932 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 25.44 per share. | 26 Aug 2025 | 111 | 26,384 (0%) | 0% | 25.4 | 2,824 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 21.22 per share. | 18 Jul 2025 | 1,115 | 26,495 (0%) | 0% | 21.2 | 23,660 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 23.71 per share. | 10 Jun 2025 | 65 | 27,610 (0%) | 0% | 23.7 | 1,541 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 22.46 per share. | 28 May 2025 | 109 | 27,675 (0%) | 0% | 22.5 | 2,448 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 22,919 | 27,784 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 25.46 per share. | 03 Mar 2025 | 136 | 4,953 (0%) | 0% | 25.5 | 3,463 | Common Stock |
| Biolife Soln Inc | Sean Werner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.03 per share. | 03 Mar 2025 | 88 | 4,865 (0%) | 0% | 24.0 | 2,115 | Common Stock |